AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia

BACKGROUND: Acute promyelocytic leukemia (APL) is a subset of acute myeloid leukemia (AML) which is characterized by the fusion of promyelocytic leukemia PML and retinoic acid receptor- alpha (RAR-alpha) genes. All-trans retinoic acid (ATRA) and/or arsenic trioxide (ATO) have resulted in durable cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatima, Mariam, Kakar, Salik Javed, Adnan, Fazal, Khan, Khalid, Mian, Afsar Ali, Khan, Dilawar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210361/
https://www.ncbi.nlm.nih.gov/pubmed/34140003
http://dx.doi.org/10.1186/s12885-021-08450-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210361/
https://www.ncbi.nlm.nih.gov/pubmed/34140003
http://dx.doi.org/10.1186/s12885-021-08450-y

Ejemplares similares